典型文献
Deuterated dextromethorphan/ quinidine for agitation in Alzheimer 's disease
文献摘要：
Alzheimer's disease (AD) is the most common type of neurodegenerative disorder; it affects around 47 million individuals worldwide (Prince et al., 2013). AD rose from the 12th most burdensome disease in the United States in 1990 to the sixth in 2016 in terms of disability-adjusted life years (Alzheimer's Disease, Facts and Figures 2021). The burden carried by patients and their caregivers is substantially related to neuropsychiatric symptoms, notably agitation as the disease progresses. To date, there is no Food and Drug Administration (FDA)-approved treatment for agitation in AD. The American Psychiatric Association recommends pharmacotherapy in case of failure of non-pharmacological options.
文献关键词：
中图分类号：
作者姓名：
Rita Khoury
作者机构：
Department of Psychiatry and Clinical Psychology,Saint George Hospital University Medical Center-Beirut,Lebanon.Adjunct Faculty,Department of Psychiatry and Behavioral Neuroscience,SaintLouis University School of Medicine,St.Louis,MI,USA
文献出处：
引用格式：
[1]Rita Khoury-.Deuterated dextromethorphan/ quinidine for agitation in Alzheimer 's disease)[J].中国神经再生研究（英文版）,2022(05):1013-1014
A类：
dextromethorphan,quinidine,burdensome
B类：
Deuterated,agitation,Alzheimer,disease,AD,most,common,type,neurodegenerative,disorder,affects,around,million,individuals,worldwide,Prince,rose,from,12th,United,States,sixth,terms,disability,adjusted,life,years,Disease,Facts,Figures,carried,by,patients,their,caregivers,substantially,related,neuropsychiatric,symptoms,notably,progresses,To,date,there,Food,Drug,Administration,FDA,approved,treatment,American,Psychiatric,Association,recommends,pharmacotherapy,case,failure,pharmacological,options
AB值：
0.656179
相似文献
机标中图分类号，由域田数据科技根据网络公开资料自动分析生成，仅供学习研究参考。
